Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab in persistent or recurrent cervical cancer
NCT00499031Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jun 2007
- Primary completion
- Jan 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in Cervical Cancer (CC), sponsored by GOG Foundation. Started Jun 2007; status: completed.
02
Drugs
KL-140
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00499031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499031.